German drugmaker Bayer saw underlying core earnings increase by one third in the second quarter. Photo: Getty Images

German drugmaker Bayer saw underlying core earnings increase by one third in the second quarter, helped by a gain in prescriptions of new drugs such a(...)

The Swiss drugmaker Actelion  has a dominant position in treatments for pulmonary arterial hypertension.

Actelion, Europe’s biggest biotech company, raised its full-year outlook despite posting lower-than-expected earnings, with the sales decline in an ol(...)

If Monsanto does not merge with Syngenta, its may seek alternative ways to help expand its portfolio of herbicides and agricultural chemicals

Any hostile bid by Monsanto for Swiss rival Syngenta is some way off, the US seed company’s president and chief operating officer has adding he was f(...)

Des Higgins, who developed Clustal, in 2002. Photograph: Michael Mac Sweeney/Provision

We are not always good at telling the stories of Irish scientists and the impact of their work. One of these stories concerns the extraordinary imp(...)

French finance minister Michel Sapin talks to his Greek counterpart Yanis Varoufakis (right) during an European Union finance ministers meeting in Luxembourg. Photograph: Francois Lenoir/Reuters 1:44

The European Central Bank has agreed to raise the cap on emergency funding for the Greek banking sector according to reports. Following an emergency c(...)

“Bayer has been looking to sell this business for several years and management was frustrated by its negative effect on growth and margins,” Alistair Campbell, an analyst at Berenberg said .

Bayer is to sell its diabetes devices unit to Panasonic Healthcare , a joint venture backed by buyout firm KKR, for about €1 billion to leave a busine(...)

A   woman runs past Swiss agrochemicals maker Syngenta’s logo in front of the headquarters in Basel, Switzerland. Photograph: Arnd Wiegmann/Reuters

Agrochemicals firm Syngenta on Friday rejected a $45 billion takeover offer from Monsanto, saying the offer undervalued the Swiss firm and did not ful(...)

Bayer cited the strengthening of most major currencies against the euro, including the US dollar, Chinese yuan and Swiss franc, for better outlook.  Picture: Bloomberg

Bayer raised its full-year forecast for profit and sales, citing “much more favorable” foreign exchange rates. The company’s earnings before interest,(...)

Twitter: results out tomorrow.  Photographer: Andrew Harrer/Bloomberg
For Your Diary

TODAY Results: Alkermes; Apple; Bankia; Doosan; Jones Lang LaSalle; Mylan. Meeting: Dragon Oil AGM (Intercontinental Hotel, Park Lane, London) Indi(...)

Ryanair: the low-cost carrier saw its shares fall 7 cent to €9.96, which was roughly in line with other airline stocks. Photograph: Andy Rain/EPA

EOIN BURKE-KENNEDY Major European share indexes climbed to new multi-year highs, with the world’s largest brewer, Anheuser-Busch InBev, leading the f(...)